U.S. markets open in 3 hours 31 minutes
  • S&P Futures

    3,830.00
    -4.00 (-0.10%)
     
  • Dow Futures

    30,907.00
    -29.00 (-0.09%)
     
  • Nasdaq Futures

    11,797.25
    -11.25 (-0.10%)
     
  • Russell 2000 Futures

    1,739.10
    -2.60 (-0.15%)
     
  • Crude Oil

    99.77
    +0.27 (+0.27%)
     
  • Gold

    1,763.40
    -0.50 (-0.03%)
     
  • Silver

    19.16
    +0.03 (+0.18%)
     
  • EUR/USD

    1.0227
    -0.0043 (-0.42%)
     
  • 10-Yr Bond

    2.8090
    0.0000 (0.00%)
     
  • Vix

    27.90
    +0.37 (+1.34%)
     
  • GBP/USD

    1.1941
    -0.0011 (-0.09%)
     
  • USD/JPY

    135.3450
    -0.4970 (-0.37%)
     
  • BTC-USD

    20,187.38
    +484.48 (+2.46%)
     
  • CMC Crypto 200

    438.11
    -1.92 (-0.44%)
     
  • FTSE 100

    7,130.30
    +104.83 (+1.49%)
     
  • Nikkei 225

    26,107.65
    -315.82 (-1.20%)
     

MMIT Announces the Winners of the Patient Access Awards

·2 min read

Winners across eight therapeutic areas are recognized by payers and physicians for their dedication to smoothing patient access

MMIT Patient Access Awards

Honoring pharmaceutical manufacturers committed to improving patient access to life-saving therapies.
Honoring pharmaceutical manufacturers committed to improving patient access to life-saving therapies.

Yardley, PA, June 23, 2022 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural Patient Access Awards to honor pharmaceutical manufacturers committed to improving patient access to life-saving therapies.

“We’re thrilled to recognize the critical role that manufacturers play in the success of a patient’s healthcare journey,” said Diane Watson, CEO of MMIT, a Norstella company. “Our hope is that this recognition inspires the industry to continue working to ensure that much-needed therapies get into the hands of the patients who need them.”

The winners—one per therapeutic area—are determined by payer and physician stakeholders, who are surveyed as part of MMIT’s quarterly Oncology Index and Biologics and Injectables Index.

In this research, payer and physician stakeholders assess and rank the performance of pharmaceutical manufacturers across a series of factors, including their overall commitment to a disease, account representative support, patient and family support programs and resources, patient copay assistance, physician education, and support and HUB services.

“MMIT extends a heartfelt congratulations to each of the winners,” said Watson. “We’re so proud to recognize your success and admirable dedication to patients.”

The winners of the inaugural Patient Access Awards are:

Oncology:

Biologics & Injectables:

Learn more information about the Patient Access Awards here.

About MMIT

MMIT, a Norstella company, is focused on solving the “what and why” of market access, and has been a trusted, go-to-market partner to more than 1,300 biopharma and payer customers for nearly three decades. MMIT believes that patients who need life-saving treatments should not face delays because accessing drugs can be confusing. MMIT’s expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions. For more information, visit mmitnetwork.com and follow us on LinkedIn.

Attachment

CONTACT: Melody Udell Managed Markets Insight & Technology, LLC 1-312-618-5968 mudell@mmitnetwork.com